Toxic Effect of Babesiosis in Cattle and Chemotherapiotic Treatment in Egypt

Ahlam F. Hamoda¹, Mervat Radwan^2, , Rabab Rashed³ and Aziza Amin⁴

¹Department of Forensic Medicine and Toxocology

²Department of Vetrinary Medicine

³Department of Pharmacology, Hospital, Banha University

⁴Department of Pathology Banha University

Cite this paper:
Ahlam F. Hamoda, Mervat Radwan, Rabab Rashed and Aziza Amin. Toxic Effect of Babesiosis in Cattle and Chemotherapiotic Treatment in Egypt. American Journal of Infectious Diseases and Microbiology. 2014; 2(5):91-96. doi: 10.12691/ajidm-2-5-1

Abstract

Babesia bigemina plays an important role in causing liver and kidney dysfunction in affected animals. The aim of this study evaluating the toxic effect of babesiosis on liver and kidney by measuring biochemical parameters and pathological tissue changes in infected animals with B. Bigemina and chose the best method of treatment. A total of 40 cattle age 1-3 years 30 were suffered from increase in temperatures, off food, Hemoglobin urea, red water from endemic area with babesia. Take sample from infected animals & examine it with microscopic examination found babesia bigemina and confirm by inoculation of heparinized blood from this animals in rats and found rats death at fifth day from infection and histopathological exam found babesia in piroplasma form in pathological tissue of rat’s liver & kidney. The infected animals were divided into three groups each group 10 animals untreated group use as control positive and treated groups divided into two groups first group treated with imidocarb only and the second group use imidocarb and lincomcyn as antibiotic drug and compare between two groups by measuring liver& kidney function improvement and compare two groups with negative and positive group which method of treatment more effective in treatment of babesia & decrease toxic effect of babesia.

Keywords:
cattle babeseosis histopathological changes in expermintal infected rat

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Henri J. Vial *, A. Gorenflot Chemotherapy against babesiosis Veterinary Parasitology 138 (2006) 147-160.
[2]	Trotta M, Carli E,Novari G, clinicopathological findings, moleculer detection and characterization of babesia gibsoni infection in a sack dog from italy vet-parasitol 2009, 165-318-322.
[3]	Rubino G,Cito Am, Lacinior, Hematology and some blood chemical parameters as function of tick-borne disease signs in hors. J Equine Vet. Sci 2006: 26: 475-480.
[4]	Rafag RB, Mrljk V, KucerN et.al. Protein C activity in babesiosis of dogs, Vet. Arhir, 2007, 77, 1-8.
[5]	ZobbaR Adru M, Niccolini S, et. al. Clinical laboratory finding in equine piroplasmosis, J.equine Vet. Sci. 2008, 28, 301-308.
[6]	Kamlie BicRk, yeten Deger, Sedar Deger, some biochemical and haematological parameters of sheep infected with babesia species YYU vet Fak Derg 2005,16 (1): 33-35.
[7]	Omer O.H., EL-MALIK K.H, MAGZOUB M. MAHMOUD O.M., HAROUN E.M., HAWAS A., OMAR H.M.: Biochemical profiles in Friesian cattle naturally infected with Theileria annulata in Saudi Arabia vet. Res. Comm., 2003, 271-25.
[8]	YADa C.K. Shurma N.N, changes in blood chemical compoents during experimentally in duced Theileria annulate infections in cattle Vet. Parasitol 1986; 21, 91-98.
[9]	Mosqueda J,Olevera-Ranirez A, Aguilar-Tipacamu GJ Current advances in detection and treatment of babesiosis. Curr Med Chem.2012: 19 (10), 1504-18.
[10]	Bock R. L.Dackson, A.DE vos and W.Jorgensen. Babesiosis of cattle parasitology (2004), 5247-5269.
[11]	Koracevic, D, Koracevic,. G. et al, Total Antioxidant Capacity. J Clin Pathol. 54, 356-361 (2001) El-Aaser, A.A. (unpublished).
[12]	Spach DH,Liles WC, Campbell GL, quick RE, Anderson DE, fritsche TR. Tick-borne diseases in the united states. N Engl J Med. 1993; 30: 936-47.
[13]	El Sawalhy, A. A. (1999): “Veterinary Infectious Diseases” 2nd Edit. Ahram Distribution Agency, Egypt.
[14]	Sumamsetty, MD, PHD, Zena Khalil MD,Pamela, Schori,MT (ASCP), Migul Azar, MD, Babesiosis two atypical cases from minnestota and review, Am. J. Clin. Pathol. 2003: 120,554-559.
[15]	Gelfand JA. Babasia. In: Mandell GL, Douglas RG, Bennett JE, DolinR, eds. Mandell, Douglas and Bennett’s, principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone, 2000; 2899-902.
[16]	Pruthi RK, Marshall WF, Wiltsie JC, Persing DH. Human babesiosis. Mayo Clin Proc. 1995; 70: 853-62.
[17]	Boustani MR, Gelfand JA. Babesiosis. Clin infect Dis. 1996; 22: 611-5. Cats. Afr.vet.ver. (2000) 71 (1): 53-5.
[18]	Bonoan JT, Johnson DH, Cunha BA. Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone. Heart Lung. 1998; 27: 424-8.
[19]	Loutan L, Rossier J, Zufferey G, Cuenod D, Hatz C, Marti HP, Gern L. Imported babesiosis diagnosed as malaria [Letter]. Lancet. 1993; 342: 749.
[20]	DKhil,M.A. S.AL. Quraishy, A.S. Abdel Baki. Hepatic tissue damage induced in meriones ungliculatus due to infection with Babesia divergens-infected erythrocytes Saudi journal of Biological sciences (2010) 17, 129-132.
[21]	Otsuka, Y.,Amasaki, M.,Yamato, O.,Maede,Y. Theeffectof macrophages on the erythrocytes oxidative damage and pathogenesis of anemia in babesia gibsoni infected dogs with low parasitemia J. Vet. Med. 2002 D. Sci. 64: 221-223.
[22]	Mathe A,Voros K,Nemeth T,Biksi IHetyey C,Manczur F,Tekes L clinicopathological changes and effect of imidocarb therapy in dogs experimentally infected with Babesia canis Acta Vet Hung 2006 Mar; 54 (1): 19-33.
[23]	Rees p, schoman JP plasma insulin concentrations in hypoglycemic dogs with Bbesia canis rossi infection Vet Parasitol 2008; 152: 60-66.
[24]	Angel Tomas CAMACHOa, Francisco Javier GUITIANb, Estrella PALLASc, Juan Jesus GESTALd, Sonia OLMEDAe, Heidi GOETHERTf, g, Sam TELFORD IIIf,g, Andrew SPIELMANf. Serum protein response and renal failure in canine Babesia annae infection Vet. Res. 36 (2005) 713-722 713.
[25]	Okubo K, Yokoyama N, Takabatake N, Okamura M, Igarashi I.2007, Amount of cholesterol in host membrane affects erythrocyte invasion and replication by Babesia bovis, Parasitology. 2007 May; 134 (Pt 5): 625-30. Epub 2006 Dec 6.
[26]	Bijan Esmaeilnejad, Mousa Tavassoli, Siamak Asri-Rezaei, Invistigation of hematological and biochemical parameters in small ruminants naturally infected with Babesia ovis Vetrinary Research Forum. 2012; 3 (1) 31-36.
[27]	El Moghazy F.M, Impact of parasitic infection on Ovaraian Activity in Buffaloes-Heifers with Emphasis on Ascariasis, World journal of Zoology 6 (2): 196-203,2011.
[28]	Sumamsetty, MD, PhD. zena khalil MD, Pamela schori, MT (ASCP), migul Azar, MD. Babisiosis two Atypical cases from Minnestota and review, Am. J. clin. pathol. 2003: 120: 554-559.
[29]	White DJ, Talarico J,chang HG, Birkhead GS, Heimberger Tm Morse DL. Human babesiosis in New York state: Review of 139 hospitalized cases and analysis of prognostic factors. Arch intern Med. 1998; 158: 2149-54.
[30]	Camacho At,Guitian FJ,Pallas E, et. al. Serum protein response and renal failure in canine babesia annae infection Vet. Res. 2005, 36, 713-722.
[31]	Mathe A, Dobos, Kovacs M,Voros K, Histological and ultrastructure studies of renal lesions in Babesia canis infected dogs treated with imidocarb, Acta Vet Hung 2007 Dec; 55 (4): 511-23.
[32]	Wittner M,Rowin KS, TanowitzHB, Hobbs jf, SsltzmanS, WenzB. Successful chemotherapy of transfusion babesiosis. Ann Intern Med. 1982, 96, 601-4.
[33]	Rowin KS, Tanoitz HB, Wittner M. therapy of experimental babesiosis. Ann Intern Med. 1982, 97, 556-8.
[34]	Krause PJ, Spielman Am Telford SR 3rd, Sikand VK, McKay K, Chrisianson D, et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 1998; 339: 160-5.
[35]	Pezhorn Bl, Lewis BD, Lopez-Rebolla LM and Swan GE, Tydskr S.S, nscreening of five drugs for efficacy against babesia felis in experimentally infected, South Africa Vet. Ass. 2000, 71: 1: 53-57.
[36]	Marcia L.Buck., pharm.D., FccP. Use of clindamycin in pediatric infection volume 14 number 2 february 2008.
[37]	Dorota M. Radomska-Leśniewska, Ewa Skopińska-Różewska, Jacek Malejczyk, Lincocin Experimental immunology. The effect of clindamycin and lincomycin on angiogenic activity of human blood mononuclear cells Centre Eur J Immunol 2010, 35 (4) 217-222.